Article
Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus.
Journal of acquired immune deficiency syndromes (1999) - 1 Sept 2006
Van Rompay Koen K A, Kearney Brian P, Sexton Jonathan J, Colón Roxana, Lawson Jonathan R, Blackwood Emily J, Lee William A, Bischofberger Norbert, Marthas Marta L
Abstract excerpt
Simian immunodeficiency virus (SIV) infection of infant macaques is a useful animal model of pediatric HIV infection to evaluate the potential of chemoprophylactic regimens to reduce mother-to-infant transmission of HIV. Previous studies have demonstrated that short-term subcutaneous administration of the reverse transcriptase inhibitor tenofovir was highly effective in protecting newborn macaques against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
